Astal Laboratories Surges 4.99% Amid Market Decline, Signaling Potential Recovery
2025-04-01 15:25:05Astal Laboratories Ltd is witnessing significant buying activity today, with the stock rising by 4.99%. This performance stands in stark contrast to the Sensex, which has declined by 1.78%. Notably, Astal Laboratories has reversed a trend of five consecutive days of losses, indicating a potential shift in market sentiment. Over the past week, the stock has decreased by 3.86%, while the Sensex fell by 2.54%. However, Astal Laboratories has shown remarkable resilience over the past year, boasting a 95.21% increase compared to the Sensex's modest 2.73% gain. The stock's performance over three years is particularly impressive, with a 370.80% rise against the Sensex's 28.28%. Today's trading saw the stock reach an intraday high of Rs 79.8, reflecting a 4.99% increase, while the intraday low was Rs 72.9, marking a decline of 4.09%. Despite the recent gains, Astal Laboratories is currently trading below its 5-da...
Read MoreAstal Laboratories Faces Intense Selling Pressure Amid Consecutive Losses and Market Sentiment Shift
2025-03-26 14:00:06Astal Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past three days, with a total decline of 5.39% during this period. Today, the stock fell by 5.00%, markedly underperforming the Sensex, which decreased by only 0.75%. In terms of broader performance, Astal Laboratories has struggled over the past month, with a decline of 6.51%, while the Sensex gained 3.79%. Year-to-date, the stock is down 2.65%, compared to the Sensex's modest decline of 0.91%. Despite a strong three-year performance of 339.03% and a ten-year increase of 260.87%, recent trends indicate a shift in market sentiment. The stock's price summary reveals an intraday high of Rs 87.15 and a low of Rs 80, reflecting volatility. Additionally, Astal Laboratories is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day movi...
Read MoreAstal Laboratories Ltd Experiences Notable Buying Surge, Achieves Significant Price Milestone
2025-03-21 09:50:04Astal Laboratories Ltd is currently witnessing significant buying activity, with the stock gaining 4.22% today, outperforming the Sensex, which rose by only 0.30%. This marks the second consecutive day of gains for Astal Laboratories, with a total increase of 10.51% over this period. The stock opened with a gap up of 4.21% and reached an intraday high of Rs 84. In terms of performance metrics, Astal Laboratories has shown a year-to-date increase of 3.70%, contrasting with the Sensex's decline of 2.00%. Over the past three years, the stock has surged by 281.30%, significantly outpacing the Sensex's growth of 33.66%. However, its performance over the last month and three months has been negative, with declines of 2.88% and 2.85%, respectively. The stock's trading today has been characterized by a narrow range of Rs 0.11, and it is currently above its 5-day, 20-day, and 50-day moving averages, although it re...
Read MoreAstal Laboratories Ltd Experiences Significant Buying Activity Amidst Potential Trend Reversal
2025-03-20 09:40:06Astal Laboratories Ltd is currently witnessing significant buying activity, marking a notable performance in the trading sector. Today, the stock surged by 6.04%, significantly outperforming the Sensex, which recorded a modest gain of 0.67%. This uptick comes after a streak of five consecutive days of declines, indicating a potential trend reversal. The stock opened with a gap up of 5.25% and reached an intraday high of Rs 80.6, reflecting strong buyer interest. Despite this positive movement, Astal Laboratories has faced challenges over the past week, month, and quarter, with declines of 2.89%, 7.14%, and 6.78%, respectively. However, its year-to-date performance shows a slight decline of 0.49%, which is better than the Sensex's drop of 2.80%. Over the longer term, Astal Laboratories has demonstrated impressive growth, with a 247.71% increase over three years and a remarkable 268.88% rise over the past d...
Read MoreAstal Laboratories Faces Intense Selling Pressure Amid Consecutive Losses and Underperformance
2025-03-17 12:55:04Astal Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past three days, resulting in a total decline of 8.29% during this period. Today, the stock opened with a gap down of 3.24% and has since fallen by 5.00%, underperforming its sector by 5.91%. The intraday low reached Rs 79, reflecting a drop of 4.82%. In terms of performance relative to the Sensex, Astal Laboratories has consistently lagged. Over the past week, the stock has declined by 6.12%, while the Sensex has only dipped by 0.16%. Over the past month, Astal Laboratories is down 4.42% compared to the Sensex's decline of 2.63%. Year-to-date, the stock has decreased by 2.65%, while the Sensex has fallen by 5.30%. Despite a strong long-term performance, with a 240.16% increase over three years and 260.87% over ten years, the recent tr...
Read MoreAstal Laboratories Achieves Notable Gains Amid Strong Buying Activity and Market Outperformance
2025-03-11 14:15:04Astal Laboratories Ltd is currently witnessing significant buying activity, with the stock showing a notable performance against the broader market. Today, Astal Laboratories recorded a gain of 3.35%, significantly outperforming the Sensex, which only increased by 0.06%. Over the past week, the stock has risen by 7.83%, compared to the Sensex's 1.60% gain. In the month, Astal Laboratories has achieved a 2.90% increase, while the Sensex has declined by 2.80%. Year-to-date, the stock is up 7.16%, contrasting with the Sensex's drop of 5.10%. Over a three-year period, Astal Laboratories has surged by an impressive 311.76%, compared to the Sensex's 33.49% increase, and over ten years, it has risen by 297.25% against the Sensex's 158.75%. The stock opened with a gap up and reached an intraday high, reflecting strong buyer sentiment. The performance metrics indicate that Astal Laboratories is trading above its ...
Read MoreAstal Laboratories Ltd Achieves Notable Price Surge Amid Strong Buying Activity
2025-02-25 15:21:24Astal Laboratories Ltd is witnessing significant buying activity, marking a notable performance in the trading sector. Today, the stock surged by 4.99%, significantly outperforming the Sensex, which only saw a modest increase of 0.14%. This follows a week where Astal Laboratories gained 7.44%, contrasting with the Sensex's decline of 1.85%. The stock has shown resilience, bouncing back after two consecutive days of decline, indicating a potential trend reversal. The intraday high reached Rs 84.34, reflecting strong buyer interest. Over the past month, Astal Laboratories has managed a 2.85% increase, while the Sensex has dipped by 2.14%. In terms of longer-term performance, Astal Laboratories has demonstrated impressive growth, with a staggering 517.88% increase over three years compared to the Sensex's 33.48%. The stock's current price is above its 5-day, 50-day, and 200-day moving averages, although it...
Read MoreAstal Laboratories Ltd Experiences Surge in Buying Activity and Price Gains
2025-02-19 11:49:11Astal Laboratories Ltd is witnessing significant buying activity, marking a notable performance in the trading sector. The stock has surged by 6.50% today, significantly outperforming the Sensex, which only saw a modest increase of 0.14%. This uptick follows a trend reversal after two consecutive days of decline, indicating a renewed interest among buyers. Over the past week, Astal Laboratories has gained 4.32%, while the Sensex has dipped by 0.13%. The stock's performance over the past month is particularly impressive, with a 16.32% increase compared to a slight decline of 0.71% in the Sensex. Year-to-date, Astal Laboratories has managed a gain of 3.21%, contrasting with the Sensex's drop of 2.64%. Today's trading saw the stock reach an intraday high of Rs 83.6, reflecting strong buyer momentum. Additionally, the stock is currently above its 5-day, 50-day, and 200-day moving averages, although it remains...
Read More
Astal Laboratories Reports Strong Q4 Growth with Significant Profit Increases and Improved Efficiency
2025-01-27 20:00:33Astal Laboratories announced its financial results for the quarter ending December 2024, revealing significant year-on-year growth. Key metrics include a notable increase in Profit Before Tax, Profit After Tax, and record-high net sales. The company also reported improved operating profit margins and earnings per share, indicating enhanced operational efficiency.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Apr-2025 | Source : BSESubmission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended March 2025.
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
06-Apr-2025 | Source : BSESubmission of Intimation regarding issue of duplicate share certificates.
Closure of Trading Window
26-Mar-2025 | Source : BSEIntimation of closure of trading window for declaration of Audited financial results for the quarter ended 31st March 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available